Suppr超能文献

糖尿病患者中FIB-4与全因死亡率、心血管死亡率及心血管疾病风险之间的关联:1999 - 2008年美国国家健康与营养检查调查(NHANES)

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999-2008.

作者信息

Guan Lihua, Li Lei, Zou Yutong, Zhong Jian, Qiu Ling

机构信息

Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.

State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.

出版信息

Front Cardiovasc Med. 2023 Sep 25;10:1172178. doi: 10.3389/fcvm.2023.1172178. eCollection 2023.

Abstract

BACKGROUND

Diabetes is prevalent worldwide and is associated with cardiovascular disease (CVD). Furthermore, due to the insulin resistance, diabetic populations are vulnerable to liver fibrosis, which increases the risk of CVD. Fibrosis-4 index (FIB-4)-a non-invasive biomarker for liver fibrosis-is crucial in predicting CVD among patients with liver diseases. However, the association between FIB-4, death, and CVD in the US diabetic population has not yet been investigated.

METHOD

We conducted a cross-sectional study using the data from the National Health and Nutrition Examination Survey (NHANES) 1999-2008. The mortality status was obtained from the National Death Index through December 31, 2015. Participants were divided into survivor and mortality group to compare the basic characteristics. The association between FIB-4, death, and CVD was analyzed using the restricted cubic spline method and Cox proportional hazards models. In stratified analysis, Participants were stratified based on age, sex, BMI, hypertension, or eGFR respectively.

RESULTS

The participants ( = 3,471) were divided into survivor ( = 1,785) and mortality groups ( = 1,632), with the mortality group exhibiting significantly higher FIB-4 values. Moreover, the risk of all-cause mortality (HR 1.24; 95% CI, 1.17-1.32) and CVD mortality (HR 1.17; 95% CI, 1.04-1.31) increased with each FIB-4 SD increase after adjusting for all covariates. However, except for myocardial infarction, FIB-4 had no significant effect on the incidence of the other three CVD subtypes (congestive heart failure, coronary heart disease, and angina pectoris). In stratified analysis, we found that the effect of FIB-4 on CVD mortality was influenced by age, and FIB-4 is a risk factor for people older than 60 years (HR 1.14; 95% CI, 1.01-1.29).

CONCLUSION

Using data from NHANES 1999-2008, FIB-4 was found to be associated with all-cause and CVD mortality in the diabetic population, and this association was significantly affected by age. However, FIB-4 only affected the incidence of myocardial infarction. Future work should investigate the association between FIB-4 and CVD in the diabetic population.

摘要

背景

糖尿病在全球范围内普遍存在,且与心血管疾病(CVD)相关。此外,由于胰岛素抵抗,糖尿病患者易患肝纤维化,这增加了心血管疾病的风险。纤维化-4指数(FIB-4)——一种用于肝纤维化的非侵入性生物标志物——在预测肝病患者的心血管疾病方面至关重要。然而,在美国糖尿病患者中,FIB-4与死亡及心血管疾病之间的关联尚未得到研究。

方法

我们使用1999 - 2008年美国国家健康与营养检查调查(NHANES)的数据进行了一项横断面研究。通过国家死亡指数获取截至2015年12月31日的死亡状况。将参与者分为存活组和死亡组以比较基本特征。使用受限立方样条法和Cox比例风险模型分析FIB-4、死亡与心血管疾病之间的关联。在分层分析中,分别根据年龄、性别、体重指数、高血压或估算肾小球滤过率(eGFR)对参与者进行分层。

结果

参与者(n = 3471)被分为存活组(n = 1785)和死亡组(n = 1632),死亡组的FIB-4值显著更高。此外,在调整所有协变量后,随着FIB-4标准差每增加一个单位,全因死亡率(风险比[HR] 1.24;95%置信区间[CI],1.17 - 1.32)和心血管疾病死亡率(HR 1.17;95% CI,1.04 - 1.31)增加。然而,除心肌梗死外,FIB-4对其他三种心血管疾病亚型(充血性心力衰竭、冠心病和心绞痛)的发病率没有显著影响。在分层分析中,我们发现FIB-4对心血管疾病死亡率的影响受年龄影响,对于60岁以上人群,FIB-4是一个风险因素(HR 1.14;95% CI,1.01 - 1.29)。

结论

利用1999 - 2008年NHANES的数据,发现FIB-4与糖尿病患者的全因死亡率和心血管疾病死亡率相关,且这种关联受年龄显著影响。然而,FIB-4仅影响心肌梗死的发病率。未来的工作应研究糖尿病患者中FIB-4与心血管疾病之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4c2/10560879/474716218559/fcvm-10-1172178-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验